COPD bronchodilator cardiovascular risks comparable

The risk for cardiovascular events among older patients with chronic obstructive pulmonary disease is similar if they begin treatment with long-acting ß-agonists or muscarinic antagonists, show results from a large, population-based study.
Source: MedWire News - Cardiology - Category: Cardiology Source Type: news